Advances in blood pressure genomics

Area of Science:

• Genetics
• Cardiovascular Disease
• Genomics

Background:

• Mendelian hypertension involves rare variants affecting sodium homeostasis.
• Common genetic variants with modest blood pressure effects (<1 mmHg systolic) are increasingly discovered.
• These common variants collectively explain less than 3% of blood pressure variance.

Purpose of the Study:

• To review advances in understanding the genetic architecture of blood pressure.
• To explore the potential of genomic discoveries for patient benefit in cardiovascular disease.
• To assess the relevance of new genomic resources for variant annotation and therapeutic target identification.

Main Methods:

• Review of recent advances in genomics and high-throughput genotyping.
• Utilizing resources like the 1000 Genomes Project and Encyclopedia of DNA Elements.
• Analysis of gene discoveries related to blood pressure and cardiovascular disease.

Main Results:

• Rare variants have significant effects on Mendelian hypertension.
• Common variants contribute modestly to blood pressure variation.
• Genomic insights offer potential for mechanistic understanding of blood pressure regulation.

Conclusions:

• Genomic discoveries may enhance cardiovascular risk assessment.
• Gene discoveries could aid in stratifying patient response to medications.
• New biological pathways for therapeutic targets may be identified through genetic research.